Logo image of CETX

CEMTREX INC (CETX) Stock Fundamental Analysis

NASDAQ:CETX - Nasdaq - US15130G7097 - Common Stock - Currency: USD

2.35  -0.05 (-2.08%)

Fundamental Rating

3

Taking everything into account, CETX scores 3 out of 10 in our fundamental rating. CETX was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. CETX has a bad profitability rating. Also its financial health evaluation is rather negative. CETX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CETX had negative earnings in the past year.
In the past year CETX has reported a negative cash flow from operations.
In the past 5 years CETX always reported negative net income.
In the past 5 years CETX always reported negative operating cash flow.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

CETX has a worse Return On Assets (-16.39%) than 70.83% of its industry peers.
Looking at the Return On Equity, with a value of -153.47%, CETX is doing worse than 90.83% of the companies in the same industry.
Industry RankSector Rank
ROA -16.39%
ROE -153.47%
ROIC N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

CETX has a Gross Margin of 41.10%. This is in the better half of the industry: CETX outperforms 72.50% of its industry peers.
CETX's Gross Margin has been stable in the last couple of years.
CETX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

CETX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CETX has been reduced compared to 1 year ago.
CETX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CETX has an improved debt to assets ratio.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.83, we must say that CETX is in the distress zone and has some risk of bankruptcy.
CETX has a Altman-Z score of -0.83. This is amonst the worse of the industry: CETX underperforms 81.67% of its industry peers.
CETX has a Debt/Equity ratio of 2.82. This is a high value indicating a heavy dependency on external financing.
CETX has a worse Debt to Equity ratio (2.82) than 97.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.82
Debt/FCF N/A
Altman-Z -0.83
ROIC/WACCN/A
WACC4.75%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.44 indicates that CETX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.44, CETX is doing worse than 80.00% of the companies in the same industry.
CETX has a Quick Ratio of 1.06. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
CETX has a Quick ratio of 1.06. This is in the lower half of the industry: CETX underperforms 78.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.06
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

CETX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -5755.23%.
CETX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.63%.
The Revenue has been growing by 11.21% on average over the past years. This is quite good.
EPS 1Y (TTM)-5755.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%283.27%
Revenue 1Y (TTM)12.63%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%7.13%

3.2 Future

Based on estimates for the next years, CETX will show a very strong growth in Earnings Per Share. The EPS will grow by 89.28% on average per year.
Based on estimates for the next years, CETX will show a quite strong growth in Revenue. The Revenue will grow by 15.00% on average per year.
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100K -100K 200K -200K 300K

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
CETX is valuated cheaply with a Price/Forward Earnings ratio of 4.19.
99.17% of the companies in the same industry are more expensive than CETX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 92.74. CETX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.19
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

CETX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CETX's earnings are expected to grow with 89.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEMTREX INC

NASDAQ:CETX (2/5/2025, 2:43:44 PM)

2.35

-0.05 (-2.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)12-19 2024-12-19/amc
Earnings (Next)02-10 2025-02-10
Inst Owners4.31%
Inst Owner Change-2.36%
Ins Owners0.39%
Ins Owner Change0%
Market Cap3.15M
Analysts82.86
Price TargetN/A
Short Float %4.16%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend15.14
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.25%
Min Revenue beat(2)-15.62%
Max Revenue beat(2)-0.88%
Revenue beat(4)2
Avg Revenue beat(4)-2.26%
Min Revenue beat(4)-15.62%
Max Revenue beat(4)4.78%
Revenue beat(8)4
Avg Revenue beat(8)0.38%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.19
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB 3.14
EV/EBITDA N/A
EPS(TTM)-687.99
EYN/A
EPS(NY)0.56
Fwd EY23.87%
FCF(TTM)-3.92
FCFYN/A
OCF(TTM)-2.95
OCFYN/A
SpS49.9
BVpS3.52
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.39%
ROE -153.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.1%
FCFM N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
F-Score5
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 2.82
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.64%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.06
Altman-Z -0.83
F-Score5
WACC4.75%
ROIC/WACCN/A
Cap/Depr(3y)155.23%
Cap/Depr(5y)125.9%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5755.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%283.27%
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.63%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%7.13%
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-212.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.89%
OCF growth 3YN/A
OCF growth 5YN/A